| 1 | 1375134 | Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase. | Cancer Chemother Pharmacol | 1992 |
1 |
| 2 | 1380647 | Hemimethylation and hypersensitivity are early events in transcriptional reactivation of human inactive X-linked genes in a hamster x human somatic cell hybrid. | Mol Cell Biol | 1992 Sep |
2 |
| 3 | 1526648 | Recombinant pollen allergens from Dactylis glomerata: preliminary evidence that human IgE cross-reactivity between Dac g II and Lol p I/II is increased following grass pollen immunotherapy. | Immunology | 1992 Jul |
2 |
| 4 | 1700230 | Induction of cytidine deaminase in HL-60 myeloid leukemic cells by 5-aza-2'-deoxycytidine. | Leuk Res | 1990 |
2 |
| 5 | 1703037 | Increased sensitivity of nontumorigenic fibroblasts expressing ras or myc oncogenes to malignant transformation induced by 5-aza-2'-deoxycytidine. | Cancer Res | 1991 Jan 1 |
1 |
| 6 | 1703777 | Potentiation of MyoD1 activity by 5-aza-2'-deoxycytidine. | Cell Growth Differ | 1990 Aug |
2 |
| 7 | 1718589 | Development of resistance to the growth inhibitory effects of transforming growth factor beta 1 during the spontaneous transformation of rat liver epithelial cells. | Cancer Res | 1991 Nov 1 |
1 |
| 8 | 1722592 | Gene silencing in mammalian cells by direct incorporation of electroporated 5-methyl-2'-deoxycytidine 5'-triphosphate. | Somat Cell Mol Genet | 1991 Nov |
2 |
| 9 | 2408746 | DNA alkali-labile sites induced by incorporation of 5-aza-2'-deoxycytidine into DNA of mouse leukemia L1210 cells. | Cancer Res | 1985 Jul |
1 |
| 10 | 2428479 | Differences in DNA damage produced by incorporation of 5-aza-2'-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells. | Cancer Res | 1986 Nov |
1 |
| 11 | 2437196 | DNA methylation alters chromatin structure and regulates Thy-1 expression in EL-4 T cells. | J Immunol | 1987 May 15 |
3 |
| 12 | 2450140 | Regulated expression of tumor-specific and MHC class I antigens in an ultraviolet radiation-induced murine skin cancer. | J Invest Dermatol | 1988 Mar |
4 |
| 13 | 2466014 | Preclinical antitumor activity of 5-aza-2'-deoxycytidine against human and neck cancer xenografts [corrected]. | Invest New Drugs | 1988 Dec |
1 |
| 14 | 2475231 | Activation and demethylation of the intracisternal A particle genes by 5-azacytidine. | Cell Differ Dev | 1989 Jul |
1 |
| 15 | 2476282 | 5-Azadeoxycytidine induced undercondensation in the giant X chromosomes of Microtus agrestis. | Chromosoma | 1989 Aug |
1 |
| 16 | 2480188 | Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine. | Cancer Chemother Pharmacol | 1989 |
1 |
| 17 | 2548078 | Use of a glucocorticoid-inducible promoter for expression of herpes simplex virus type 1 glycoprotein gC1, a cytotoxic protein in mammalian cells. | Mol Cell Biol | 1989 Jun |
1 |
| 18 | 2578963 | Comparison of the in vitro cytotoxicity (L1210) of 5-aza-2'-deoxycytidine with its therapeutic and toxic effects in mice. | Eur J Cancer Clin Oncol | 1985 Jan |
2 |
| 19 | 2659542 | Characterization of a novel mouse reticular cell sarcoma M5076 subline resistant to cisplatin. | Int J Cancer | 1989 Jun 15 |
1 |
| 20 | 3024333 | Reactivation of X-linked genes in human fibroblasts transformed by origin-defective SV40. | Somat Cell Mol Genet | 1986 Nov |
2 |
| 21 | 6084549 | Effects of 5-aza-2'-deoxycytidine in combination with the biochemical modulator thymidine or the immune modulator pyran copolymer on L1210 leukemia-bearing mice. | Cancer Treat Rep | 1984 Oct |
1 |
| 22 | 6175964 | Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine. | Proc Natl Acad Sci U S A | 1982 Feb |
1 |
| 23 | 6189497 | Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside. | Biochem Pharmacol | 1983 Apr 1 |
1 |
| 24 | 6191192 | Incorporation of 5-Aza-2'-deoxycytidine-5'-triphosphate into DNA. Interactions with mammalian DNA polymerase alpha and DNA methylase. | Mol Pharmacol | 1983 Jul |
2 |
| 25 | 7481843 | Induction of resistance to 2',2'-difluorodeoxycytidine in the human ovarian cancer cell line A2780. | Semin Oncol | 1995 Aug |
1 |
| 26 | 7511051 | Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine. | Cancer Res | 1994 Apr 1 |
10 |
| 27 | 7511899 | Regulation of folate-binding protein gene expression by DNA methylation in methotrexate-resistant KB cells. | Biochem Pharmacol | 1994 Mar 15 |
3 |
| 28 | 7514437 | 5-Aza-2'-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells. | Ann Oncol | 1994 Mar |
1 |
| 29 | 7519483 | Enhancement of the antileukemic activity of 5-aza-2'-deoxycytidine by cyclopentenyl cytosine in HL-60 leukemic cells. | Anticancer Drugs | 1994 Apr |
1 |
| 30 | 7532033 | Transfection of wild-type deoxycytidine kinase (dck) cDNA into an AraC- and DAC-resistant rat leukemic cell line of clonal origin fully restores drug sensitivity. | Blood | 1995 Mar 1 |
2 |
| 31 | 7536040 | Transcriptional regulation of the mts1 gene in human lymphoma cells: the role of DNA-methylation. | Biochim Biophys Acta | 1995 Apr 4 |
2 |
| 32 | 7541096 | De novo induced mutations in the deoxycytidine kinase (dck) gene in rat leukemic clonal cell lines confer resistance to cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC). | Leukemia | 1995 Jun |
9 |
| 33 | 7543292 | In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) gene. | Ann Hematol | 1995 Jul |
10 |
| 34 | 7578983 | Transcriptional upregulation of TGF-alpha by phenylacetate and phenylbutyrate is associated with differentiation of human melanoma cells. | Cytokine | 1995 Jul |
1 |
| 35 | 7683359 | Effects of 5-aza-2'-deoxycytidine on differentiation and oncogene expression in the human monoblastic leukemia cell line U-937. | Leukemia | 1993 May |
1 |
| 36 | 7686601 | Role of deoxycytidine kinase in an in vitro model for AraC- and DAC-resistance: substrate-enzyme interactions with deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-aza-2'-deoxycytidine. | Leukemia | 1993 Jul |
4 |
| 37 | 7687384 | Hemidemethylation is sufficient for chromatin relaxation and transcriptional activation of methylated aprt gene in mouse P19 embryonal carcinoma cell line. | Somat Cell Mol Genet | 1993 May |
1 |
| 38 | 7937876 | Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. | Proc Natl Acad Sci U S A | 1994 Oct 11 |
1 |
| 39 | 8033147 | Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780. | Cancer Res | 1994 Aug 1 |
1 |
| 40 | 8336727 | Activation of an imprinted Igf 2 gene in mouse somatic cell cultures. | Mol Cell Biol | 1993 Aug |
2 |
| 41 | 8625319 | Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. | Cancer Res | 1996 May 15 |
4 |
| 42 | 8631003 | Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. | Cancer Res | 1996 Feb 15 |
1 |
| 43 | 8663390 | Promoter-specific modulation of insulin-like growth factor II genomic imprinting by inhibitors of DNA methylation. | J Biol Chem | 1996 Jul 26 |
1 |
| 44 | 8665502 | Hypermethylation of the p16 gene in nasopharyngeal carcinoma. | Cancer Res | 1996 Jun 15 |
1 |
| 45 | 8698626 | Induction of MAGE genes in lymphoid cells by the demethylating agent 5-aza-2'-deoxycytidine. | Jpn J Cancer Res | 1996 Jul |
4 |
| 46 | 8707418 | Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells. | Int J Cancer | 1996 Jul 29 |
2 |
| 47 | 8757382 | Expression of MAGE genes in human colorectal carcinoma. | Ann Surg | 1996 Aug |
2 |
| 48 | 8760298 | Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. | Oncogene | 1996 Aug 1 |
2 |
| 49 | 8842727 | Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors. | Hum Mol Genet | 1996 Aug |
2 |
| 50 | 8886971 | Epigenetic control of mammalian centromere protein binding: does DNA methylation have a role? | J Cell Sci | 1996 Sep |
1 |